Gelonghui, August 15 | Wanhua Media (00426.HK) announced that the board of directors of the company will hold a board meeting on August 29, 2024 (Thursday) on the 16th floor of Block A, Ming Pao Industrial Centre, 18 Ka Yip Street, Chai Wan, Hong Kong to approve (including) the quarterly results of the company and its subsidiaries for the first quarter ended June 30, 2024.
- Headlines
- One Media Group (00426.HK) held a board of directors meeting on August 29 to approve the first quarter performance.
万华媒体(00426.HK)8月29日举行董事会会议批准第一季度业绩
One Media Group (00426.HK) held a board of directors meeting on August 29 to approve the first quarter performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
18:31
The australian dollar against the US dollar AUD/USD has declined by 0.50% today, currently at 0.6418.
18:31
India's central bank kept the benchmark interest rate unchanged at 6.5%, exceeding expectations of a reserve requirement reduction.
18:30
imeik technology development: The clinical trial for the recombinant human hyaluronidase injection has been approved.
Imeik Technology Development+3.22%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.